INSIGHTS ON DRUG DEVELOPMENT

• Why Reshoring Is An Essential Strategy For ADC Supply Chain Security

  Biotechs reshoring their supply chains to Western regions to mitigate risk and improve reliability require experienced partners to effectively manage these complex transitions.

• Developing High Concentration Biopharmaceuticals: Formulation Considerations

  This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and presents case studies on how composition changes during the concentration process can be effectively characterized.

• Advanced Therapies Going Mainstream: Are We There Yet?

  Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.

• Patient-Centric Formulations In Pediatric Adherence

  Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.

• Fast And Scalable Fc Quantitation In Supernatants

  3/24/2025

  In biopharmaceutical development, the Fc PAIA Titer assay offers a fast, cost-effective, and automatable solution for high-throughput Fc quantification to enhance efficiency, support research, and accelerate production advancements.

• Rapid Walkaway Solution For Assessing Viability In Cancer Organoids

  3/31/2025

  Assess anti-cancer compounds' effects on organoid size and morphology with colorectal cancer organoids as well as discover automated imaging and viability assays to streamline drug screening and aid early identification.

• Assessing The Success Of CRISPR Gene Therapies Using ddPCR Technology

  3/4/2026

  Achieve high-fidelity results in gene therapy research. Discover how absolute quantification overcomes traditional limitations to provide the precision needed for validating CRISPR edits.

• Together, Let's Sail Toward Success

  7/23/2025

  Explore the promise and complexity of gene therapy and see how Cytiva empowers scientists to overcome challenges and accelerate life-changing treatments from lab to patient.

• Modeling Virus Evolution, Rapid Drug Repurposing With Human Airway Lung-Chips

  8/2/2024

  In this presentation, we introduce the human Airway Lung-Chip, which can model influenza virus infection and evolution in vitro and evaluate therapeutics for both influenza and SARS-CoV-2.